NU 6102 5mg 5mg | Purity Not Available
Adooq Bioscience
NU6102 is selective for CDK1 and CDK2 compared to CDK4/D1 (IC50=1.6 ??M), DYRK1A (IC50=0.9 ??M), PDK1 (IC50=0.8 ??M) and ROCKII (IC50=0.6 ??M).
More Information Supplier PageNU6102 is selective for CDK1 and CDK2 compared to CDK4/D1 (IC50=1.6 ??M), DYRK1A (IC50=0.9 ??M), PDK1 (IC50=0.8 ??M) and ROCKII (IC50=0.6 ??M).
More Information Supplier PageNU6102 is selective for CDK1 and CDK2 compared to CDK4/D1 (IC50=1.6 ??M), DYRK1A (IC50=0.9 ??M), PDK1 (IC50=0.8 ??M) and ROCKII (IC50=0.6 ??M).
More Information Supplier PageNU6102 is selective for CDK1 and CDK2 compared to CDK4/D1 (IC50=1.6 ??M), DYRK1A (IC50=0.9 ??M), PDK1 (IC50=0.8 ??M) and ROCKII (IC50=0.6 ??M).
More Information Supplier PageSU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and RET.
More Information Supplier PageSU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and RET.
More Information Supplier PageSU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and RET.
More Information Supplier PageHalofuginone is a semisynthetic quinazolinone alkaloid anticoccidial derived from the plant Dichroa febrifuga, with antifibrotic and potential antineoplastic activities.
More Information Supplier PageHalofuginone is a semisynthetic quinazolinone alkaloid anticoccidial derived from the plant Dichroa febrifuga, with antifibrotic and potential antineoplastic activities.
More Information Supplier Page